DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Ajooni Biotech Limited — Issue of Securities

NSE 3 hrs ago·31 Jul 2026, 12:06 pm

Ajooni Biotech

Ajooni Biotech Limited has informed stock exchanges about the issuance of new securities. This corporate action typically involves raising fresh capital by issuing shares, warrants, or convertible instruments to investors.

For investors, this development signals the company's intent to fund its growth plans, such as expanding operations or investing in new projects. It is generally viewed as a positive step for long-term value creation, provided the funds are deployed effectively.

Investors should monitor the specific details of the issue, including the price and purpose of the fund raising, to understand its impact on the company's financial health and future prospects.